Accra, Ghana//-Dannex Ayrton Starwin Plc today informed its valued shareholders, customers, and the general investing public that the Securities and Exchange Commission (SEC), Ghana, has granted the company an extension of time to submit and publish its audited financial statements for the year ended December 31. 2025.
This is contained in a brief statement issued and signed by the Chief Finance Officer of the Accra-based pharmaceutical manufacturing company.
It is, however, assured that the new date for submission and publication of the company’s full-year 2025 financial statements is April 30. 2026.
“The Company appreciates your continued understanding and support”., the statement said.
It would recall that Dannex Ayrton Starwin Plc had bounced back strongly from a loss of GH¢1.02 million in the first quarter of 2023 to post a profit of GH¢5.42 million in the first quarter of 2024.
This was after the company halved its exchange rate losses from GH¢1.31 million in the first quarter of 2023 to GH¢635.4 million in the first quarter of 2024.
Total revenue also grew from GH¢27.22 million in the first quarter of 2023 to GH¢39.39 million in the first quarter of 2024, with cost of sales also increasing from GH¢12.56 million to GH¢16.36 million.
Administrative expenses also increased from GH¢10.17 million to GH¢12.38 million.
Total assets also grew from GH¢76.32 million in the first quarter of 2023 to GH¢90.47 million in the first quarter of 2024, with total liabilities also growing from GH¢70.46 million to GH¢70.99 million.
